Posted on 3/6/18
Johnson & Johnson: Upside Available If You're Willing To Take On Some Risks
Johnson & Johnson (JNJ) engages in the research and development, manufacture and sale of a range of products in the healthcare industry. They are well diversified . . .
Posted on 3/6/18
Celgene Announces Expiration of Cash Tender Offer for Shares of Juno Therapeutics
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Juno Therapeutics, . . .
Posted on 3/6/18
SCYNEXIS Announces Launch of Public Offering of Common Stock and Warrants
SCYNEXIS, Inc. (Nasdaq: SCYX) today announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of . . .
Posted on 3/5/18
Amarin Announces Closing of Underwriter’s Purchase of Additional Shares
BEDMINSTER, N.J., and DUBLIN, Ireland, March 05, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that, in connection with its previously announced underwritten public . . .
Posted on 3/5/18
VirtualHealth and SAS Collaborate
VirtualHealth, the leading SaaS platform for care management and population health, announced today a new joint effort with SAS to support whole person care. The integration . . .
Posted on 3/5/18
Actinium Announces $15.4 Million in Expected Gross Proceeds from Recently Expired Rights Offering
Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) announced today that the Company’s previously announced rights offering (“the Rights Offering”) expired on Friday, March 2, 2018 and these rights are . . .
Posted on 3/2/18
Tyme Technologies Prices its Offering of 9 Million Shares of Common Stock
NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME) announced today that it has priced its underwritten public offering of 9 million shares . . .
Posted on 3/2/18
Celgene's $6 Billion Blunder: Time to Throw in the Towel on the Biotech Stock?
When Celgene (NASDAQ:CELG) makes a mistake, it's a doozy.The big biotech reported on Tuesday that it had received a Refusal to File letter from the U.S. . . .
Posted on 3/2/18
Protalex Announces Completion of $1.425 Million Private Placement
FLORHAM PARK, N.J.--(BUSINESS WIRE)--Protalex, Inc. (OTCQB: PRTX), a clinical-stage biopharmaceutical company, today announced that on February 28, 2018, it consummated a private placement financing to accredited . . .
Posted on 3/1/18
Celgene's Run of Bad Luck Continues
Eager to diversify its revenue away from multiple myeloma treatments, Celgene(NASDAQ:CELG)spent $7.2 billion in 2015 to acquire the promising multiple sclerosis drug candidate ozanimod. Then, it . . .
Posted on 3/1/18
Zelis Healthcare Wins Four Stevie Awards For Sales & Customer Service
BEDMINSTER, N.J.--(BUSINESS WIRE)--Zelis® Healthcare, a market-leading provider of integrated healthcare cost management and payments solutions, was presented with three Silver Stevies®, one Bronze Stevie and a . . .
Posted on 2/28/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on February 26, 2018 it approved non-statutory stock options to purchase an aggregate of 96,750 shares of its . . .
Posted on 2/28/18
Dr. Krawitz Eye Vitamins Partners with The Vitamin Shoppe
With yesterday's announcement of the release of Dr. Krawitz Dry Eye Support, Vitamin Science®, a world leader in eye vitamins, announces the completion of a formidable . . .
Posted on 2/28/18
Acorda Enters Into Cooperation Agreement with Scopia
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that it has entered into a cooperation agreement with Scopia Capital Management LP.“We appreciate the constructive dialogue we . . .
Posted on 2/28/18
Boston Children's Hospital & Klick Health Announce VR Platform
Boston Children's Hospital and Klick Health today unveiled the HealthVoyager™ medical education and patient experience platform – a Proof of Concept that uses Virtual Reality (VR) . . .
Posted on 2/28/18
Johnson & Johnson Still Showing Geron Much Love
With days or weeks before the final interim review for Geron's (GERN) Imetelstat in the iMbark Myelofibrosis "MF" trial, its time for investors to consider the . . .
Posted on 2/28/18
Johnson & Johnson Might Seal The Deal With Geron This Year
Investment ThesisWith days or weeks before the final interim review for Geron's (GERN) Imetelstat in the iMbark Myelofibrosis "MF" trial, its time for investors to consider . . .
Posted on 2/26/18
Tyme Technologies Announces Offering of Common Stock
NEW YORK, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage biotechnology company developing cancer therapeutics, today announced that it had commenced an . . .
Posted on 2/26/18
LifeThreads' Antimicrobial Textiles Named to Becker's Hospital Review "100 Infection Control Products to Know - 2018"
Becker's Hospital Review, a respected monthly healthcare trade publication, has named LifeThreads® LLC's (www.life-threads.com) antimicrobial textiles to its "100 Infection Control Products to Know – 2018" . . .
Posted on 2/26/18
East River Medical Imaging Joins LabFinder.com
LabFinder.com, has announced that East River Medical Imaging locations are now available to book through their online platform. Patients and providers can schedule, access and share . . .
Posted on 2/23/18
Would Pfizer Investors Win With a Bristol-Myers Squibb Acquisition?
You can almost hear the sound of keyboards at Pfizer's (NYSE:PFE) headquarters in New York crunching the numbers on potential deals. The giant drugmaker was eerily . . .
Posted on 2/23/18
Advaxis Prices $20.0 Million Public Offering of Common Stock
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of cancer immunotherapies, announced today the pricing of its previously . . .
Posted on 2/22/18
Can Johnson & Johnson Replace Remicade for $100 Million Upfront?
As huge piles of overseas cash make their way back to big U.S. drugmakers, biotech buyoutsdominate the headlines. While most of us were watching the big . . .
Posted on 2/21/18
Glenmark Pharmaceuticals Enters Exclusive Collaboration Agreement with SCD Pharmaceuticals
Glenmark Pharmaceuticals, a global pharmaceutical company, today announced it has entered into an exclusive agreement with Sam Chun Dang Pharm. Co. Ltd. (SCD), to develop, manufacture . . .
Posted on 2/21/18
Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock
CRANBURY, N.J., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today announced the closing of its previously announced offering of common stock. The Company issued . . .

